Jag Capital Management’s Charles River Laboratories CRL Stock Holding History

Jag Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,943	Closed	-$577K	–	151
2023 Q3	$577K	Buy	2,943 +25	+0.9%	+$5.13K	0.07%	112
2023 Q2	$614K	Hold	2,918	–	–	0.07%	114
2023 Q1	$589K	Hold	2,918	–	–	0.08%	117
2022 Q4	$636K	Hold	2,918	–	–	0.09%	113
2022 Q3	$574K	Sell	2,918 -4,000	-58%	-$864K	0.08%	123
2022 Q2	$1.48M	Buy	+6,918	New	+$1.69M	0.18%	92
2022 Q1	–	Sell	-48,452	Closed	-$18.3M	–	219
2021 Q4	$18.3M	Sell	48,452 -1,295	-3%	-$503K	1.4%	27
2021 Q3	$20.5M	Buy	49,747 +9,758	+24%	+$4.05M	1.6%	25
2021 Q2	$14.8M	Buy	+39,989	New	+$13.4M	1.16%	30

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Jag Capital Management's CRL Position: Q4 2023 in Review

Jag Capital Management sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 2,943 shares — an estimated $577K sold.

Jag Capital Management first reported a position in CRL in Q2 2021 and held it in 9 quarters. The position peaked at $20.5M in Q3 2021. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

Jag Capital Management reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
Jag Capital Management sold 2,943 Charles River Laboratories shares in Q4 2023, an estimated $577K.
Jag Capital Management first reported a position in Charles River Laboratories in Q2 2021 and held it in 9 quarters.
Jag Capital Management's Charles River Laboratories position peaked at $20.5M in Q3 2021.
634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Jag Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.